Prot#TAK-018-2001: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2a Study to Evaluate the Safety, Tolerability, and Early Proof of Concept of TAK-018 for the Prevention of Postoperative Crohn's Disease Recurrence

Project: Research project

Project Details

StatusFinished
Effective start/end date12/17/21 → 12/17/24

Funding

  • Pharmaceutical Research Associates, Inc. (Prot#TAK-018-2001 // Prot#TAK-018-2001)
  • Millennium Pharmaceuticals, Inc. (Prot#TAK-018-2001 // Prot#TAK-018-2001)